Targeting the HPA axis—such as by blocking glucocorticoid effects with agents like RU486 or inhibiting CRH signaling with antagonists like antalarmin—is thus being explored as a strategy to improve seizure control while also addressing stress-related psychiatric comorbidities in epilepsy [72]. The gene discussed is CRH; the disease is epilepsy.